deCODE biostructures Expands Collaboration with InterMune
News Jun 12, 2007
deCODE biostructures, Inc. announces the initiation of a third research project with InterMune, Inc. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target.
The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life™ technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.
Chemical Compound Class Possesses Potential for Treating Zika VirusNews
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study.READ MORE
Lab Innovations 2018 – Registration Opens and Keynotes AnnouncedNews
Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.READ MORE